维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="HOUSSIAU F"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Thirty years of cyclophosphamide: assessing the evidence 显示文摘	HOUSSIAU F	2007	Lupus2007，16，3：	1
2	Effect of belimumab treatment on renal outcomes : results from the phase 3 belimumab clinical trials in patients with SLE 显示文摘	Dooley MA Houssiau F Aranow C	2013	Lupus2013，22，1：	1
3	The10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide显示文摘	HOUSSIAU F A VASCONCELOS C D'CRUZ D	2010	Ann Rheum Dis2010，69，1：	1
4	Immunosuppressive therapy in lupus nephritis : the Euro-Lupus Nephritis Trial, a randomized trial of Iou-dose versus high-dose intravenous Cyclophosphamide显示文摘	Houssiau F A Vasconcelos C D Cruz D	2002	Arthritis Rheum2002，46，：	1
5	The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclopho-sphamide显示文摘	Houssiau F A Vasconcelos C D\'Cruz D	2010	Ann Rheumatic Dis2010，69，1：	1
6	Human p40/IL-9 expression in activated CD4 + T cells,genomic organization,and comparison with the mouse gene显示文摘	Renauld JC Goethals A Houssiau F	1990	J Immunol1990，144，11：	1
7	Cyclophosphamide in lupus nephritis显示文摘	Houssiau F	2005	Lupus2005，14，：	1
8	Effect of belimumab treatment on renal outcomes:results from the phase 3 belimumab clinical trials in patients with SLE显示文摘	Dooley MA Houssiau F Aranow C	2013	Lupus2013，22，1：	1
9	Thirty years of cyclophosphamide:assessing the evidence显示文摘	HOUSSIAU F	2007	Lupus2007，16，3：	1
10	Cyclophosphamide in Lupus nephritis显示文摘	Houssiau F	2005	Lupus2005，14，1：	1
11	Human P40/IL-9 ex- pression in actived CIM T cell, genomic organization, and com- parison with the mouse gene 显示文摘	Renauld JC Goethals A Houssiau F	1990	J Immunol1990，144，11：	1
12	Interleulin-6 in synovial fluid and serum of patient with rheumatoid arthritis and anther inflammatory authorities显示文摘	Houssiau F A Pevogelaer J P	1988	Arthretis Rheum1988，31，6：	1
13	Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18 显示文摘	Lauwerys B R Renauld J C Houssiau F A	1999	Cytokine1999，11，11：	1
14	Synergistic activation of human T cells by interleukin-1 and interleukin 6 显示文摘	Houssiau F A Coulie P G Olive D	1988	Immunol1988，18，：	1
15	Thirty years of cyclophophamide : assessing the evidence 显示文摘	Houssiau F	2007	Lupus2007，16，3：	1
16	Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides显示文摘	Devogelaer J Y Van Damme J	1988	Arthritis Rheum1988，31，：	1
17	A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis 显示文摘	WESTHOVENS R HOUSSIAU F JOLY J	2006	J Rheumatol2006，33，5：	1
18	Azathioprine versus mycophenolate mofetil for long-term immunosuppre-ssion in lupus nephritis:results from the MAINTAIN Nephritis Trial显示文摘	Houssiau F A D′Cruz D Sangle S	2010	Ann Rheum Dis2010，69，12：	1
19	Human P40/IL-9 expression in activated CD4+ T cells,genomic organization,and comparison with the mouse gene显示文摘	Renauld JC Goethals A Houssiau F	1990	J Immunol1990，144，11：	1
20	Scintigraphy using a technetium 99m - labelled anti - E - selectin Fab fragment in rheumatoid arthritis显示文摘	Jamar F Houssiau FA Devogelaer JP	2002	Bheumatology (Oxford)2002，41，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示